• TerraBioGen Technologies

  Led · Grant · Jul 2016

  TerraBioGen Technologies Inc., based in Vancouver, British Columbia, develops proprietary high-value, environmentally sustainable bioproducts and biostimulants aimed at improving crop health, yields, and stress tolerance. Its core products are agriculturally bioactive formulations for use in agricultural and horticultural crops. The company emphasizes research and development and works with university partners to improve effectiveness and create new product lines. TerraBioGen is taking steps to secure intellectual property rights and to formulate products for full commercialization. Financially, the company closed a private placement on June 29, 2017, raising $576,000 through the sale of 192,000 units at $3.00 per unit. Each unit includes one common share and a five-year warrant exercisable at $5.00; proceeds will fund R&D, university collaborations, next-generation formulations, and cooperative field trials. TerraBioGen Technologies develops proprietary, high-value bioproducts and plant biostimulants intended to improve crop health, yields, and abiotic and biotic stress tolerance. The company focuses on research and development to improve effectiveness, expand product lines, and secure intellectual property and formulations for commercialization. It received a $37,500 funding award to support market demonstration and development of its next-generation plant biostimulant products in British Columbia's ornamental plant and floriculture industries. The project expands trials beyond prior poinsettia work to other potted plant varieties, cut flowers, foliar crops, and bedding plants. Management states the goal is to enable growers to produce a better product at lower cost. TerraBioGen is based in Vancouver, British Columbia. TerraBioGen Technologies develops proprietary, high‑value agriculturally bioactive products intended to improve crop health and yields and suppress crop disease. The company focuses on research and development to improve product effectiveness, quality, and to create new product lines. It is also working to formulate active ingredients and to secure intellectual property rights for commercialization. TerraBioGen plans to use recent financing to enhance commercialization through further product development, field trials, and collaboration development. The company announced a private placement raising $420,000 to support those commercialization and IP efforts. Headquarters are in Vancouver, Canada. TerraBioGen Technologies develops proprietary, high-value agriculturally bioactive products intended to improve crop health and yields and to suppress crop disease. The company emphasizes research and development to improve product effectiveness, quality and to create new product lines. It is pursuing formulation work and steps to secure intellectual property rights for its active ingredients. Recent financing will be deployed to enhance commercialization through further product development, field trials and collaboration development. The company is headquartered in Vancouver, British Columbia. The press release emphasizes forward-looking plans but notes results are not guaranteed. TerraBioGen Technologies Inc. is a developer of proprietary high-value agriculturally bioactive products based in Vancouver, British Columbia. The company focuses on research and development to improve the efficiency of its technology, its methodology, and the quality of its agricultural products. It is committed to developing a worldwide marketing capability to ensure market acceptance of its products. In April 2014 TerraBioGen completed a private placement raising $210,000 through the sale of 21,000 units at $10 each. Each unit consisted of one common share and a warrant exercisable at $12 per share for five years. The company said the proceeds will fund 2014 growing trials across a wide range of crops and to continue research and development activities.

No current team members are available.